Læknablaðið - 01.04.1977, Síða 27

HaLCiDöRm
in dermatology
“
r
topical halcinonide 0.1 %
\\
• ^ i /
\ ^ _________- -
^ 'W -Ví%
/ * * v
£^4 «r" -w V.\_*
-anew
corticosteroid
-aunique
bi-phasic base
giving controlled
potency for
prolonged activity
an advanced ePProaCh ‘° *<<*> tfeatment
• immediate penetration
• sustained activity
• excellent results in eczema
• significantly better
than betamethasone
17 valerate in the treatment
of psoriasis.
SQUIBB
Further irtformation on request: E. R. Squibb and S;ns Limitea -:.a ~ ■■■ ckenham, TW1 3QT.